Valuation IDEXX Laboratories, Inc.
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 555.67 USD | -2.56% |
|
+5.55% | -17.86% |
| 06-30 | IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell Midcap Value Benchmark | CI |
| 06-29 | IDEXX Laboratories, Inc.(NasdaqGS:IDXX) added to Russell 1000 Value Benchmark | CI |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 44,983 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | -16.73% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 45,119 | 44,580 | 44,253 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | -17.5% | -1.19% | -0.73% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 38.9x | 34.4x | 30.4x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 21.3x | 15.6x | 11.7x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 3.2x | 2.7x | 2.3x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 9.55x | 8.79x | 8.06x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 9.58x | 8.72x | 7.93x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 26.9x | 24.1x | 21.6x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 29.7x | 26.5x | 23.5x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 39x | 34.5x | 30.4x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.57% | 2.9% | 3.29% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 14.67 | 16.55 | 18.75 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,709 | 5,115 | 5,581 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,680 | 1,847 | 2,045 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,521 | 1,685 | 1,881 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,170 | 1,304 | 1,462 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 135.9 | -403.3 | -729.8 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 570.25 | 570.25 | 570.25 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,883 | - | - |
| Announcement Date | 2/2/22 | 6/2/23 | 5/2/24 | 3/2/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- Valuation IDEXX Laboratories, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
